Influence of Patient Preferences on the Cost-Effectiveness of Screening for Lynch Syndrome
This cost-utility analysis reports on the effect of quality of life on the value of screening all new patients with colorectal cancer for Lynch Syndrome.
Health Technology Assessment and Private Payers's Coverage of Personalized Medicine
A study of major US private payers showed an important role and considerable shortcomings of external health technology assessment in coverage decisions on personalized medicine.
Genomic Testing and Therapies for Breast Cancer in Clinical Practice
Despite almost universal testing for human-epidermal-growth-factor-receptor-2 (HER2), many women with a HER2-positive cancer may not receive trastuzumab. Fewer women received the newer gene-expression-profile (GEP) test.
Genetic Testing and Pharmacogenomics: Issues for Determining the Impact to Healthcare Delivery and Costs
Willingness to Recommend a Health Plan: Who Is Dissatisfied and What Don't They Like?
Does Patient Cost Sharing Matter? Its Impact on Recommended Versus Controversial Cancer Screening Services
2 Clarke Drive Cranbury, NJ 08512